Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Northwest A&F University has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is distributed across a distinct examiner and a distinct art unit, reflecting a singular point of contact for the university's current patent applications. The focus on a single art unit indicates that the university's active research and development efforts in this sector are currently being evaluated by a specific group of technical experts at the patent office.
CHOWDHURY, IQBAL HOSSAIN is the busiest examiner for the portfolio, managing the 1 busiest examiner pending action. The success of the university's current efforts in this technology area is tied to the review of this individual examiner, making their specific history and art unit's trends a primary consideration for the applicant. Understanding the examiner's typical approach to biotechnology claims will be essential for navigating the current pending matter effectively.
With CHOWDHURY, IQBAL HOSSAIN overseeing the only active case, the university can streamline its communication and strategy. This concentration of work means that the university's immediate patenting prospects in the Biotechnology & Pharmaceuticals area are subject to the interpretations of a single official. A successful resolution of the pending office action would clear the current prosecution queue for the university in this specific technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHOWDHURY, IQBAL HOSSAIN | 1 | 73.6% | +57.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18340513 | STREPTOMYCES ARDESIACUS, MICROBIAL BIOLOGICAL CONTROL AGENT (MBCA) AND USE | CHOWDHURY, IQBAL HOSSAIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18340513 | STREPTOMYCES ARDESIACUS, MICROBIAL BIOLOGICAL CONTROL AGENT (MBCA) AND USE | CHOWDHURY, IQBAL HOSSAIN | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18340513 | STREPTOMYCES ARDESIACUS, MICROBIAL BIOLOGICAL CONTROL AGENT (MBCA) AND USE | CHOWDHURY, IQBAL HOSSAIN | 1656 | §101§112 | Non-Final OA | — | Pending | Jun 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNorthwest A&F University has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Iqbal Hossain Chowdhury has the most, with 1 of Northwest A&F University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
